Price
Financials
Consolidated, Rs crore| Dec 2023 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 1.60 | 2.52 | 1.02 | 2.39 | 1.92 | 0.96 | 1.83 | 0.49 |
| Expenses | 0.05 | 0.04 | 1.58 | 2.83 | 2.11 | 2.31 | 2.15 | 1.41 | 2.71 | 1.02 |
| Operating Profit | -0.05 | -0.04 | 0.02 | -0.31 | -1.09 | 0.08 | -0.23 | -0.45 | -0.88 | -0.53 |
| OPM % | 1.25% | -12.30% | -106.86% | 3.35% | -11.98% | -46.88% | -48.09% | -108.16% | ||
| Other Income | 1.37 | 0.35 | 0.04 | 0.15 | -0.18 | 0.03 | 0.04 | 0.08 | 0.15 | 0.06 |
| Interest | 0.00 | 0.00 | 0.13 | 0.11 | -0.23 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.13 | 0.14 | 0.15 | 0.12 | 0.12 | 0.12 | 0.12 | 0.11 |
| Profit before tax | 1.32 | 0.31 | -0.20 | -0.41 | -1.19 | -0.02 | -0.31 | -0.49 | -0.85 | -0.58 |
| Tax % | 18.94% | 19.35% | 30.00% | -4.88% | -8.40% | 0.00% | 0.00% | 0.00% | -64.71% | 0.00% |
| Net Profit | 1.07 | 0.25 | -0.25 | -0.39 | -1.08 | -0.02 | -0.31 | -0.48 | -0.30 | -0.57 |
| EPS in Rs | 5.59 | 1.31 | -1.31 | -2.04 | -5.64 | -0.10 | -1.62 | -2.51 | -1.57 | -2.98 |
| Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|
| Sales | 0.00 | 6.96 | 6.99 | 5.20 |
| Expenses | 0.12 | 9.21 | 8.47 | 7.29 |
| Operating Profit | -0.12 | -2.25 | -1.48 | -2.09 |
| OPM % | -32.33% | -21.17% | -40.19% | |
| Other Income | 2.00 | 0.38 | 0.31 | 0.33 |
| Interest | 0.00 | 0.01 | 0.02 | 0.00 |
| Depreciation | 0.00 | 0.54 | 0.48 | 0.47 |
| Profit before tax | 1.88 | -2.42 | -1.67 | -2.23 |
| Tax % | 18.09% | -2.07% | -32.93% | |
| Net Profit | 1.54 | -2.37 | -1.12 | -1.66 |
| EPS in Rs | 8.04 | -12.38 | -5.85 | -8.68 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | % | % | -31% | ||
| Compounded Profit Growth | % | % | % | 5% | ||
| Stock Price CAGR | -2% | 30% | -2% | -47% | ||
| Return on Equity | % | % | % | -13% |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Equity Capital | 1.92 | 1.92 | |
| Reserves | 7.07 | 6.08 | |
| Borrowings | 7.20 | 8.42 | |
| Other Liabilities | 3.91 | 3.02 | |
| Total Liabilities | 20.10 | 19.44 | |
| Fixed Assets | 12.03 | 11.55 | |
| CWIP | 0.00 | 0.00 | |
| Investments | 2.46 | 2.24 | |
| Other Assets | 5.61 | 5.65 | |
| Total Assets | 20.10 | 19.44 |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Cash from Operating Activity | -1.04 | -1.52 | |
| Cash from Investing Activity | -9.63 | 0.02 | |
| Cash from Financing Activity | 1.24 | 1.17 | |
| Net Cash Flow | -9.43 | -0.33 | |
| Free Cash Flow | -1.37 | -1.52 | |
| CFO/OP | 46% | 103% |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Debtor Days | 22.03 | 57.96 | |
| Inventory Days | 356.10 | ||
| Days Payable | 378.35 | ||
| Cash Conversion Cycle | 22.03 | 35.71 | |
| Working Capital Days | -27.27 | -1.57 | |
| ROCE % | -9.32% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 57.79% | 62.71% | 62.71% | 62.71% | 62.71% | 62.71% | 63.48% | 63.48% | 63.48% | 63.48% | 63.48% | 63.48% |
| Public | 42.21% | 37.29% | 37.30% | 37.29% | 37.29% | 37.28% | 36.53% | 36.52% | 36.53% | 36.52% | 36.53% | 36.53% |
| No. of Shareholders | 290 | 318 | 320 | 366 | 361 | 660 | 597 | 664 | 615 | 620 | 610 | 632 |
Fundamentals
Market Cap₹ 22.2 Cr.
Current Price₹ 116
Book Value₹ 41.8
ROCE-9.32 %
ROE-13.2 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-31%
Compounded Profit Growth (TTM)5%
Consolidated figures.
Ownership
Promoter holding63.48% (+0.00 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | 512036 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -3.2% | -2.8% | -0.4 pts |
| 1 month | -11.4% | -6.8% | -4.6 pts |
| 3 months | -34.7% | -7.6% | -27.1 pts |
| 3 years | -3.2% | +14.2% | -17.3 pts |
| 5 years | +274.8% | +27.9% | +246.9 pts |
Red flags
No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹0 Cr -79.5% vs Jun 2025.
Net loss ₹1 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| K P R Mill Ltd | 36,967 | 40.5 | 19.6 % |
| Welspun Living Ltd | 21,277 | 76.5 | 6.26 % |
| Vardhman Textiles Ltd | 15,335 | 18.1 | 8.55 % |
| Trident Ltd | 11,461 | 29.0 | 9.79 % |
| Indo Count Industries Ltd | 8,614 | 57.1 | 8.19 % |
| Garware Technical Fibres Ltd | 7,361 | 33.4 | 22.0 % |
| Kusumgar Ltd | 6,378 | 50.7 | 18.8 % |
| Filatex India Ltd | 4,973 | 25.9 | 19.1 % |
| Jindal Worldwide Ltd | 4,719 | 55.7 | 8.63 % |
| Sanathan Textiles Ltd | 4,352 | 71.6 | 6.89 % |
| Raymond Lifestyle Ltd | 4,026 | 27.0 | 3.52 % |
| Alok Industries Ltd | 3,501 | -3.95 % | |
| Nitin Spinners Ltd | 3,403 | 16.1 | 12.2 % |
| Sangam (India) Ltd | 3,248 | 25.8 | 10.7 % |
| Ganesha Ecosphere Ltd | 2,703 | 47.8 | 5.58 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Skybiotech Healthcare Limited?
Skybiotech Healthcare Limited (512036) has a market capitalisation of Rs 22.2 Cr. at the 2026-09-30 close.
What were Skybiotech Healthcare Limited's latest quarterly results?
In the Jun 2026 quarter, Skybiotech Healthcare Limited sales was Rs 0 Cr (-79.5% vs Jun 2025) with a net loss of Rs 1 Cr.